Biomaterial Database

[Polyunsaturated fatty acids and epilepsy]. 2009

Anette Huuse Farmen, and Morten I Lossius, and Karl O Nakken

Nevrologisk avdeling Sykehuset Innlandet Lillehammer Anders Sandviks gate 17 2609 Lillehammer. anette.huuse.farmen@sykehuset-innlandet.no

BACKGROUND 30 % of patients with epilepsy have recurrent drug-resistent seizures. Some children with catastrophic epilepsy have responded well to a ketogenic diet. Polyunsaturated fatty acids are at least partly responsible for the anticonvulsive effect of this diet and could perhaps be used to treat epilepsy. METHODS The paper is based on literature (published before June 2008) retrieved through a non-systematic search of the Cochrane and PubMed databases. The following search words were used: epilepsy, polyunsaturated fatty acids, clinical trials, ketogen diet, and treatment. Articles focusing on clinical aspects were selected. CONCLUSIONS Articles on clinical studies and laboratory research were retrieved from Pubmed, while studies on ketogen diet were retrieved from Cochrane. Animal studies show that increased intake of polyunsaturated fatty acids can reduce the likelihood of epileptic seizures through various biochemical mechanisms. However, there is not sufficient evidence to conclude that polyunsaturated fatty acids have antiepileptic effects in people with epilepsy. More research is needed before polyunsaturated fatty acids can be presented as a treatment option for epilepsy.

UI	MeSH Term	Description	Entries
D004827	Epilepsy	A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)	Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005231	Fatty Acids, Unsaturated	FATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds.	Fatty Acids, Polyunsaturated,Polyunsaturated Fatty Acid,Unsaturated Fatty Acid,Polyunsaturated Fatty Acids,Acid, Polyunsaturated Fatty,Acid, Unsaturated Fatty,Acids, Polyunsaturated Fatty,Acids, Unsaturated Fatty,Fatty Acid, Polyunsaturated,Fatty Acid, Unsaturated,Unsaturated Fatty Acids
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818	Animals	Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.	Animal,Metazoa,Animalia
D000927	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity.	Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D055423	Diet, Ketogenic	A course of food intake that is high in FATS and low in CARBOHYDRATES. This diet provides sufficient PROTEINS for growth but insufficient amount of carbohydrates for the energy needs of the body. A ketogenic diet generates 80-90% of caloric requirements from fats and the remainder from proteins.	Ketogenic Diet,Diets, Ketogenic,Ketogenic Diets